13

SEP-2022

Beilu Pharma Established a Wholly-owned R&D Subsidiary

13

SEP-2022

Beilu's Iopamidol Injection Won the Bid for China's Pharmaceutical Centralized Procurement

26

APR-2022

Beilu Pharma's Gadobutrol Injection Has Been Approved By NMPA

PharmaSources Customer Service